Age-related Macular Degeneration is the leading cause of blindness for Americans over the age of 65, affecting as many as 15 million people in the United States.
Individuals over the age of 65 have a one-in-four chance of developing the disease and in those over 75, the chances increase to one in three.
The majority of eye doctors in practice today recommend an antioxidant for patients with macular degeneration. This recommendation is based on the results of a 2001 published study referred to as AREDS. A new study published in 2007 demonstrated that a stablization or improvement in visual acuity may occur when patients with macular degeneration are taking TOZAL vs. an antioxidant formula based on the AREDS study.
Read about TOZAL study below
Dr. Ed Paul, product developer and patent holder
CLICK HERE or on the image to the left to view a news broadcast covering this "next generation" nutraceutical for macular degeneration, TOZAL.
CLICK HERE to order TOZAL (lower right hand corner of next page)
New Supplement For Macular Degeneration Helps Assuage Disease
Macular Degeneration
Age-related Macular Degeneration is the leading cause of blindness for Americans over the age of 65, affecting as many as 15 million people in the United States.
Individuals over the age of 65 have a one-in-four chance of developing the disease and in those over 75, the chances increase to one in three.
Imagine not being able to see the face of a grandchild, watch television or to tell what time it is.
The majority of well-meaning eye doctors in practice today were trained to believe that AMD is an untreatable and incurable disease. Subsequently, you may have been told that nothing can be done for this condition. Well, there is good news. AMD cannot only be prevented, but in many cases it can be safely treated and even reversed.
The Nutrition Connection
For years, eye doctors have been recommending antioxidant vitamins for AMD patients. Until recently, the AREDS formula was considered the standard of care in treating AMD. It found that 25 percent of patients treated with advanced AMD could slow the progressive of their vision loss by taking a supplement with antioxidants plus zinc.
In 2007, the landmark TOZAL study was published which evaluated lutein and omega-3 fatty acids in addition to the antioxidants studied in AREDS. Remarkably, the results of the TOZAL study revealed that more than half (57%) of the subjects had improved vision at six months. A total of nearly 77% treated with the TOZAL nutritional supplement improved or stayed the same. This is the first study to show both statistical and clinical significance with respect to vision improvement in patients with dry AMD. Subjects in the TOZAL study took daily doses of the carotinoid beta-carotene, 15,000 to 25,000 International Units (IU); the carotenoid lutein, 6 to 10 milligrams (mg); the carotenoid zeaxanthin, 500 mcg; zinc, 60 to 70 mg; taurine, 400 to 500 mg; Vitamin A, 5,000 to 10,000 IU; Vitamin C, 400 to 500 mg; and Vitamin E, 200 IU.
Antioxidants that protect your retina such as beta-carotene and vitamins A, C and in combination with omega-3 fatty acids may also prevent the development of this serious eye disorder. Two particular carotenoids, lutein and zeaxanthin, may be particularly beneficial. Antioxidants can be obtained from foods or supplements. Vegetables rich in carotene include orange and yellow squash, and dark, leafy greens, such as kale, collards, spinach, and watercress.
Omega-3 fatty acids also offer protection against AMD. In a study of more than 3,000 people over the age of 49, those who consumed more fish in their diet were less likely to have macular degeneration than those who consumed less fish (most types of fish are rich in omega-3 fatty acids). Similarly, a study comparing 350 people with macular degeneration to 500 without found that those with a proper ratio of omega-3 to omega-6 fatty acids and higher intake of fish in their diets were less likely to have this particular eye disorder. Another larger study found that consuming docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), two types of omega-3 fatty acids found in fish, four or more times per week may reduce the risk of developing macular degeneration.
Flavonoids (such as quercetin, rutin, and resveritrol) may also play a role in preventing macular degeneration. A study of 3,072 adults with macular changes showed that moderate red wine consumption may offer some protection against the development or progression of macular degeneration. Red wine is high in quercetin, rutin, and resveritrol, which have antioxidant activity. Damage from oxidative stress is thought to contribute to the development of AMD. Dark berries, such as blueberries, blackberries, and dark cherries, are also high in flavonoids.
Here is a look at preventive and therapeutic measures that should be followed when it comes to AMD:
1. Take a nutritional supplement based on the TOZAL study.
2. Exercise - walking is an excellent source of exercise and improves circulation.
3. Limit caffeine intake from coffee, tea, and soft drinks.
4. Quit smoking - smoking increases your risk of AMD by 350%.
5. Drink eight - 8 ounce glasses of water daily.
6. Avoid aspirin and ibuprofen.
7. Wear sunglasses or brimmed hats outside.
8. Develop a PMA - Positive Mental Attitude! By Dr. Ed Paul
